Liu D Y, Bourne H, Baker H W
Department of Obstetrics and Gynaecology, University of Melbourne, Royal Women's Hospital, Carlton, Victoria, Australia.
Fertil Steril. 1997 May;67(5):955-8. doi: 10.1016/s0015-0282(97)81415-x.
To determine whether intracytoplasmic sperm injection (ICSI) is effective treatment for patients with disordered zona pellucida (ZP)-induced acrosome reaction (AR) who have failure of standard IVF-ET.
Tests of sperm-ZP binding and penetration and the ZP-induced AR were used to diagnose patients with disordered ZP-induced AR who then were treated with ICSI.
Academic reproductive medicine research laboratory associated with a tertiary referral infertility clinic.
MAIN OUTCOME MEASURE(S): Clinical features and results of previous IVF-ET, semen analysis and sperm-ZP interaction tests, and ICSI were analyzed.
RESULT(S): The majority of patients had consistently normal sperm characteristics and all patients had normal sperm-ZP binding but failure of sperm-ZP penetration. The AR of sperm bound to the ZP was significantly lower in the patients (mean 6%, range 0% to 16%) than in the fertile men (mean 61%, range 27% to 96%). Intracytoplasmic sperm injection was performed on 34 patients and the normal fertilization rate averaged 73% per injected oocyte. Five ongoing and eight term pregnancies including two with twins were achieved after an average of two ET procedures per patient were performed. Two couples have second ongoing pregnancies from transfer of frozen embryos after successful first pregnancies. Overall, the implantation rate was 10.5% per embryo and the pregnancy rate 19% per ET and 38% per patient.
CONCLUSION(S): Disordered ZP-induced AR is a cause of severe infertility and persistent failure of IVF-ET. Intracytoplasmic sperm injection is effective treatment for this condition. Patients with idiopathic infertility should be tested for this condition before commencing IVF-ET treatment.
确定卵胞浆内单精子注射(ICSI)对于标准体外受精-胚胎移植(IVF-ET)失败且透明带(ZP)诱导的顶体反应(AR)紊乱的患者是否为有效治疗方法。
采用精子-ZP结合与穿透试验以及ZP诱导的AR试验来诊断ZP诱导的AR紊乱患者,随后对其进行ICSI治疗。
与一家三级转诊不孕不育诊所相关的学术生殖医学研究实验室。
分析既往IVF-ET的临床特征和结果、精液分析、精子-ZP相互作用试验以及ICSI情况。
大多数患者的精子特征始终正常,所有患者的精子-ZP结合均正常,但精子-ZP穿透失败。与可育男性(平均61%,范围27%至96%)相比,患者中与ZP结合的精子的AR显著降低(平均6%,范围0%至16%)。对34例患者实施了卵胞浆内单精子注射,每个注射卵母细胞的正常受精率平均为73%。每位患者平均进行两次胚胎移植(ET)程序后,获得了5例持续妊娠和8例足月妊娠,其中包括2例双胞胎。两对夫妇在首次成功妊娠后通过冷冻胚胎移植获得了第二次持续妊娠。总体而言,每个胚胎的着床率为10.5%,每次ET的妊娠率为19%,每位患者的妊娠率为38%。
ZP诱导的AR紊乱是严重不孕和IVF-ET持续失败的一个原因。卵胞浆内单精子注射是针对这种情况的有效治疗方法。特发性不孕患者在开始IVF-ET治疗前应进行此项检查。